SYNTOLOGY HomeExplorerAtlasCodeMethodologyAboutDevelopersFeedPricing
Paper · 2212.00223 · EMNLP · 2022

Biomedical NER for the Enterprise with Distillated BERN2 and the Kazu Framework

Jaewoo Kang, Wonjin Yoon, Richard Jackson, Elliot Ford, Vladimir Poroshin

arXiv · PDF · Open in the Atlas

Code that ran

We have not lifted any functions out of this paper's repositories yet, so there is nothing we have run. The repositories linked to it are listed below.

Repositories linked to this paper

Some links come from the archived Papers with Code dataset (CC BY-SA 4.0): attribution and licence.

Abstract

In order to assist the drug discovery/development process, pharmaceutical companies often apply biomedical NER and linking techniques over internal and public corpora. Decades of study of the field of BioNLP has produced a plethora of algorithms, systems and datasets. However, our experience has been that no single open source system meets all the requirements of a modern pharmaceutical company. In this work, we describe these requirements according to our experience of the industry, and present Kazu, a highly extensible, scalable open source framework designed to support BioNLP for the pharmaceutical sector. Kazu is a built around a computationally efficient version of the BERN2 NER model (TinyBERN2), and subsequently wraps several other BioNLP technologies into one coherent system.

For agents

The same record, over MCP at https://syntology.ai/mcp:

get_harvested_code_for_paper("2212.00223")
get_code_for_paper("2212.00223")
have("2212.00223")

The run record, dated, one paper per request, free:

curl https://syntology.ai/api/ran/2212.00223.json

A badge for a README (the split and the date, never a ratio):

[![Syntology run record](https://syntology.ai/api/ran/2212.00223.svg)](https://syntology.ai/paper/2212.00223)

Connect an agent — have() is free.